The Summary
In a randomized controlled trial involving 2,495 older Finnish adults (men aged 60+ and women aged 65+), researchers investigated whether daily vitamin D3 supplementation (1,600 IU or 3,200 IU) lowered fracture incidence compared to placebo over five years. Baseline blood levels showed most participants were already vitamin D-sufficient. Over up to 7.3 years of follow-up, neither dosage reduced fracture risk compared to placebo; in fact, the 1,600 IU group saw slightly higher fracture rates. The findings suggest high-dose vitamin D supplementation does not prevent fractures in aging populations with adequate baseline levels.
Why this is interesting
For years, older adults have been encouraged to take high-dose vitamin D to strengthen bones and prevent fractures. However, this rigorous trial demonstrates that if your vitamin D levels are already sufficient, taking extra daily doses provides no protective skeletal benefit. In fact, megadosing offered no advantage and was unexpectedly linked to higher fracture incidence in one group. For everyday health, more is not necessarily better: routine high-dose vitamin D is unlikely to safeguard your bones unless clinical testing shows a true underlying deficiency.